Overweight men are far more likely to get misleading results to prostate cancer tests that compromise their treatment, new research has revealed. 肥胖的男性在前列腺癌试验中更容易得到一个错误的结果从而影响他们的治疗,一项新的研究表明。
This can decrease the efficacy of the current medication and may compromise future treatment options. 这中现象不仅可减弱药效,对后期的治疗选择也不利。